UltraClear® for Facial Surgeons | Dr Anthony MacQuillan, BAAPS President
Surgery can reposition almost any tissue. It cannot change the skin covering it, and that is often what separates a good result from a stand-out one. Dr Anthony MacQuillan, consultant facial surgeon and BAAPS President, explains why UltraClear® now sits in his surgical pathway: before theatre, in theatre, and at every follow-up after it.
Every facial surgeon knows the limitation. A facelift or blepharoplasty repositions structure. The photodamage, uneven texture, pigmentation and fine lines arrive in theatre with the patient, and they leave with the patient too.
Dr MacQuillan saw the difference this makes when comparing UK outcomes with those shared by surgeons in the US, where skin treatment is routinely part of the surgical plan.
“When you look at Instagram, a lot of the results, especially in America, people get treated with the whole nine yards. So it’s not just the surgery. They get all the skin treatments as well. That’s what really makes the result pop. And I was looking to try and replicate that.”
Dr Anthony MacQuillan, BAAPS President
The patient judges the result on how they look, not on how well the tissue was repositioned. Skin quality is a large part of what they see. Before UltraClear®, Dr MacQuillan’s in-house options for that half of the result were limited.
“That was definitely something I didn’t have in my armoury before. Prior to that it was operating for nothing.”
UltraClear® is the world’s first cold ablative fractional fibre laser. It operates at 2910 nm, the peak of water absorption in human tissue. Energy goes into ablating tissue rather than heating the tissue around it.
For a surgeon, the familiar reference point is fractional CO2. Dr MacQuillan explains the difference in the terms he uses in theatre.
He had worked with erbium before, on a multi-platform system. It did not deliver the change he wanted.
SEE IT FOR YOURSELF:
“What I was looking for was something I could use in conjunction with the facelift at the time of the surgery, to treat the central portion of the face, and then do the second part, the periphery, where you’ve lifted the skin up. You wouldn’t want to treat that at the same time as the surgery, but you can use it on that part of the skin maybe three or four weeks later.”
The fourth stage is where Dr MacQuillan sees a genuine change in what surgery can offer. Surgery always leaves the skin to do some settling of its own.
“I can use it post-operatively to tweak the results once the skin has done what it’s done. So it gives you the option to modify things again after the surgery, when the skin has perhaps restructured a little, which is inevitable with surgery.”
A device that works well in a clinic room can still fail in theatre. The patient is anaesthetised and cannot reposition, space around the table is tight, and every handpiece change costs time. UltraClear® was the first laser Dr MacQuillan found that suits that environment.
Set-up is equally simple. Protocols are saved as presets, and there are no consumables to fit, replace or budget for.
“You press the buttons on the screen, you have a recipe that you like, press a button and away you go. There’s nothing you have to change on it. There are no consumables or anything. So it allows a lot of freedom.”
DISCOVER THE DIFFERENCE FIRSTHAND:
“I think it has masses of potential. I can see the tremendous results you can get.”
Dr MacQuillan, BAAPS President
If you recognise any of the following in your practice:
Then the question is no longer whether skin quality matters to your result. It is whether your surgical pathway accounts for it.